"Insider buying is generally viewed as a bullish signal. While insiders may sell for many reasons (taxes, diversification, buying a home), they typically only buy for one reason: they believe the price will rise. It can signal management's confidence in the company's future prospects or internal turnaround. Furthermore, it often suggests that the stock is undervalued by the market, especially if the purchase is made during a period of price weakness."
"RA Capital added almost 3.7 million shares, while NEA added 937,500 shares, both at the initial public offering price of $16.00 per share. SpyGlass recently announced positive Phase 2 data for its intraocular drug delivery system for glaucoma. The stock is trading near $28.20, above the IPO price. Analysts are highly bullish, with a Strong Buy consensus rating, citing the potential to disrupt the $5 billion glaucoma market."
"Suvretta Capital Management, a 10% owner, purchased 282,700 shares executed in multiple tranches at a weighted average price of approximately $36.50, totaling $10.5 million. Suvretta has been aggressively accumulating shares over the past six months, increasing its stake by nearly 20% in that period. Veradermics recently received an Overweight rating from Wells Fargo, following the successful enrollment of its Phase 3 trial for molluscum contagiosum."
Insiders and large investors increased positions in SpyGlass Pharma, Veradermics, KKR, and Reddit. RA Capital Management and New Enterprise Associates added significant shares of SpyGlass at the IPO price of $16.00, with RA Capital adding almost 3.7 million shares and NEA adding 937,500 shares. SpyGlass reported positive Phase 2 data for an intraocular glaucoma drug-delivery system and trades near $28.20 with a Strong Buy consensus and potential to disrupt a $5 billion glaucoma market. Suvretta Capital bought 282,700 Veradermics shares at a weighted average near $36.50, totaling $10.5 million, and has increased its stake nearly 20% over six months. Veradermics earned an Overweight from Wells Fargo after Phase 3 enrollment, and its shares trade around $43.46. A Reddit director purchased 50,500 shares in the $139.11–$150.00 range. KKR is also listed among names with notable insider purchases.
Read at 24/7 Wall St.
Unable to calculate read time
Collection
[
|
...
]